From Yahoo Finance: 2025-04-26 09:30:00

During a stock-market correction, investors should consider shopping for discounted stocks. Regeneron Pharmaceuticals (REGN) and Moderna (MRNA) are down 17% and 36% this year. Moderna, known for its COVID-19 vaccine, faces financial struggles but has promising clinical developments, while Regeneron has strong products and a growing pipeline.

Moderna’s innovative mRNA-based vaccines show promise in fast development and cheaper costs. Despite struggles, Moderna’s clinical progress and pipeline make it a good investment at a 36% decrease in shares. Regeneron, facing biosimilar competition, has strong products like Dupixent, a growing pipeline, and a dividend program, making it a solid investment option.

Investors seeking high-growth stocks may want to look beyond Moderna. The Motley Fool Stock Advisor identified 10 top stocks with potential for significant returns, excluding Moderna. Their average return is 872%, outperforming the S&P 500 at 160%. Don’t miss out on the next top 10 list and the chance for high returns.

Read more: 2 Stocks Down 17% and 36% This Year to Buy and Hold